Literature DB >> 8568938

Developing oligodendroglia express mRNA for insulin-like growth factor-I, a regulator of oligodendrocyte development.

Y Shinar1, F A McMorris.   

Abstract

Insulin-like growth factors IGF-I and IGF-II are potent inducers of oligodendrocyte development. Because IGF-I is produced, in some cases, by the same cells that respond to it (autocrine/paracrine action), we examined the possibility that IGF-I is expressed by developing oligodendroglial cells. We employed a sensitive method, reverse transcriptase-polymerase chain reaction (RT-PCR), to detect IGF-I mRNA in purified populations of oligodendroglial cells isolated from rat brain during the period of oligodendrocyte development. Cells were purified by fluorescence activated cell sorting (FACS), using antibodies to the cell surface antigenic markers O4 and galactocerebroside (GC). RNA was isolated from the sorted cells, reverse-transcribed, and PCR-amplified, using a strategy that recognizes IGF-I mRNA but not DNA. The amplified band was identified as IGF-I by size, hybridization to an IGF-I-specific antisense probe, and restriction analysis. IGF-I mRNA was detected in O4-positive/GC-negative oligodendrocyte precursors and, more weakly, in GC-positive oligodendrocytes. IGF-I mRNA could be detected reproducibly in RNA extracted from 100-cell samples of O4-positive cells, making it unlikely that the mRNA was derived from contaminants in the FACS-sorted cell populations. We conclude that IGF-I is expressed by developing oligodendroglia. Autocrine expression of IGF-I by developing oligodendroglial cells suggests that oligodendrocyte development is, in part, autoregulatory.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8568938     DOI: 10.1002/jnr.490420410

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  11 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

2.  p38 MAP kinase regulation of oligodendrocyte differentiation with CREB as a potential target.

Authors:  Narayan R Bhat; Peisheng Zhang; Sangeeta B Mohanty
Journal:  Neurochem Res       Date:  2007-01-19       Impact factor: 3.996

Review 3.  The insulin-like growth factor system and the fetal brain: effects of poor maternal nutrition.

Authors:  Thomas J McDonald; Mark J Nijland; Peter W Nathanielsz
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

4.  Insulin-like growth factor-1 fails to enhance central nervous system myelin repair during autoimmune demyelination.

Authors:  B Cannella; D Pitt; E Capello; C S Raine
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

5.  Interleukin-1beta promotes repair of the CNS.

Authors:  J L Mason; K Suzuki; D D Chaplin; G K Matsushima
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

Review 6.  The role of the insulin-like growth factors in the central nervous system.

Authors:  A J D'Ercole; P Ye; A S Calikoglu; G Gutierrez-Ospina
Journal:  Mol Neurobiol       Date:  1996-12       Impact factor: 5.590

7.  Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation.

Authors:  J R Chan; L J Phillips; M Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 8.  The insulin-like growth factor (IGF) receptor type 1 (IGF1R) as an essential component of the signalling network regulating neurogenesis.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2009-08-29       Impact factor: 5.590

9.  Regulated release of BDNF by cortical oligodendrocytes is mediated through metabotropic glutamate receptors and the PLC pathway.

Authors:  Issa P Bagayogo; Cheryl F Dreyfus
Journal:  ASN Neuro       Date:  2009-04-14       Impact factor: 4.146

10.  Hippocampal IGF-1 expression, neurogenesis and slowed aging: clues to longevity from mutant mice.

Authors:  Liou Y Sun
Journal:  Age (Dordr)       Date:  2006-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.